These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24054100)

  • 1. In reply.
    Edlow JA; Smith EE
    Ann Emerg Med; 2013 Oct; 62(4):433. PubMed ID: 24054100
    [No Abstract]   [Full Text] [Related]  

  • 2. The lytic lottery.
    Ellison D
    Ann Emerg Med; 2013 Oct; 62(4):432-3. PubMed ID: 24054099
    [No Abstract]   [Full Text] [Related]  

  • 3. Should a hospital without a neurologist use t-PA to treat stroke?
    Krieger DW
    Cleve Clin J Med; 1999; 66(10):585-6. PubMed ID: 10598361
    [No Abstract]   [Full Text] [Related]  

  • 4. Expectations for tPA is pathway to litigation.
    ED Manag; 2011 Feb; 23(2):18-9. PubMed ID: 21400969
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical Policy: Use of intravenous tPA for the management of acute ischemic stroke in the emergency department.
    ;
    Ann Emerg Med; 2013 Feb; 61(2):225-43. PubMed ID: 23331647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroking the data: re-analysis of the NINDS trial.
    Magid D; Naviaux N; Wears RL
    Ann Emerg Med; 2005 Apr; 45(4):385-7. PubMed ID: 15795716
    [No Abstract]   [Full Text] [Related]  

  • 7. Tissue plasminogen activator for acute ischemic stroke: a New York city emergency medicine perspective.
    Chan YF; Kwiatkowski TG; Rella JG; Rennie WP; Kwon RK; Silverman RA
    J Emerg Med; 2005 Nov; 29(4):405-8. PubMed ID: 16243196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agreement with evidence for tissue Plasminogen Activator use among emergency physicians: a cross-sectional survey.
    Grady AM; Bryant J; Carey ML; Paul CL; Sanson-Fisher RW; Levi CR
    BMC Res Notes; 2015 Jun; 8():267. PubMed ID: 26111807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Authors' reply to Wardlaw and Berge.
    Alper BS; Malone-Moses M; McLellan JS; Prasad K; Manheimer E
    BMJ; 2015 Apr; 350():h1795. PubMed ID: 25851154
    [No Abstract]   [Full Text] [Related]  

  • 10. When time matters most. Group working on new stroke readiness program.
    Lovern E
    Mod Healthc; 2001 Jun; 31(25):88. PubMed ID: 11436396
    [No Abstract]   [Full Text] [Related]  

  • 11. Drip-and-ship stroke thrombolysis in the emergency department of a healthcare center - a possibility for those fallen ill in rural settings.
    Kauppila JH; Raatiniemi L; Isokangas JM; Martikainen M; Piironen K
    Duodecim; 2017; 133(2):167-71. PubMed ID: 29205017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergency physician survey: recombinant tissue plasminogen activator for stroke.
    Walsh M; Fromm G
    Ann Emerg Med; 2006 Mar; 47(3):297. PubMed ID: 16492504
    [No Abstract]   [Full Text] [Related]  

  • 13. Tissue plasminogen activator approved for stroke.
    Barber A; Gommans J
    N Z Med J; 2005 May; 118(1214):U1432. PubMed ID: 15886728
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of tissue plasminogen activator to treat acute ischemic stroke.
    Alexandrov AW
    Crit Care Nurse; 2010 Oct; 30(5):77-8. PubMed ID: 20889516
    [No Abstract]   [Full Text] [Related]  

  • 15. Emergency physician survey: recombinant tissue plasminogen activator for stroke.
    Mann J
    Ann Emerg Med; 2006 Oct; 48(4):476; author reply 477. PubMed ID: 16997689
    [No Abstract]   [Full Text] [Related]  

  • 16. Hope on the horizon for stroke patients.
    Cornell DH
    N J Med; 1998 Apr; 95(4):61-3. PubMed ID: 16010797
    [No Abstract]   [Full Text] [Related]  

  • 17. Can the therapeutic window for tissue plasminogen activator be extended to 6 hours after stroke onset?
    Alexandrov AV
    Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):342-3. PubMed ID: 16265558
    [No Abstract]   [Full Text] [Related]  

  • 18. [Extra-hospital stroke care].
    Mateos-Rodríguez AA
    Rev Neurol; 2012 Sep; 55(5):319; author reply 319-20. PubMed ID: 22930145
    [No Abstract]   [Full Text] [Related]  

  • 19. Alteplase for ischaemic stroke.
    Burrage D
    Lancet; 2014 Oct; 384(9953):1502. PubMed ID: 25390573
    [No Abstract]   [Full Text] [Related]  

  • 20. Can quality-adjusted life-years and subgroups help us decide whether to treat late-arriving stroke patients with tissue plasminogen activator?
    Waxman DA; Keeler E
    Ann Emerg Med; 2013 Jan; 61(1):56-7. PubMed ID: 22841181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.